Prevention and Treatment of Acute Myeloid Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The State of the Art and Future Perspectives

Allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk acute myeloid leukemia (AML) represents the only curative option. Progress has been made in the last two decades in the pre-transplant induction therapies, supportive care, selection of donors and conditioning regimens that allo...

Descripción completa

Detalles Bibliográficos
Autores principales: Leotta, Salvatore, Condorelli, Annalisa, Sciortino, Roberta, Milone, Giulio Antonio, Bellofiore, Claudia, Garibaldi, Bruno, Schininà, Giovanni, Spadaro, Andrea, Cupri, Alessandra, Milone, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745746/
https://www.ncbi.nlm.nih.gov/pubmed/35011994
http://dx.doi.org/10.3390/jcm11010253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745746/
https://www.ncbi.nlm.nih.gov/pubmed/35011994
http://dx.doi.org/10.3390/jcm11010253

Ejemplares similares